Seal, Stopping Eczema and Allergy Study

Clinical trial NCT03742414 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03742414
Sponsor: Kari Nadeau, MD, PhD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Eczema, Infantile Eczema Atopic Dermatitis Eczema Atopic Dermatitis

Start date: 2021-06-30
Primary completion: 2028-05-31
Enrollment: 398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.